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growth factor-beta (TGF-pl), a regulator of cog proliferation, is regulated in 
myocardial infarction. The objective of this study was to determine the effect 
of TGF-pl on proliferation of cardiac fibroblasts under hypoxlc onditions, 
DNA synthesis was determined by measurement of 3H-thymidino incorpo- 
ration into DNA of rabbit cardiac fibroblasts under 2% (hypoxia) and 20% 
(ambient) oxygen in the absence ~md presence of 10 ng/ml purified human 
TGF-pl. In the absence of TGF-pl hypoxia (24 h) led to a 20% (p < 0,04) 
decrease in DNA synthesis In cardiac fibroblasts compared with that in cells 
incubated under ambient conditions. The 24 h reoxygenation led to a mnd- 
eat improvement of DNA synthesis. Addition of TGF-/J1 dudng this pedod 
did not effect DNA synthesis. However, hypoxia in TGF-pl-treated cells led 
to an Increase (82%, p < 0.001) in DNA synthesis cumpared with that in 
TGF-p~ -treated cells under normoxic onditions. These msu~s indicate that 
hypoxia affects the proliferative capacity of cardiac fibroblests, but it is not a 
stimulator of their proliferation. The results also suggest hat effects of growth 
factors such as TGF-~ which come i,"do play under hypoxia contn'bute to 
those mechanisms controlling hypoxia-inducod proliferation ofcardiac fibrob- 
lasts in rive. These findings also provide fuflher suppod for the previously 
suggested cardioprotestlve role of TGF-pl in hypoxic conditions. 
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~ '~ Upregulation Neutrophll Integrins and of  
Down-Regulation of L-Selectin by Plasma From 
Patients With Myocardial Infarction 
Tomasz Siminiak i Robin M. Egdeli, Daniel J. O'Gorman, Julian R Dye, 
Desmond J. Sh~.  1 Un/vem/ty of Medical Sdences, Poznan, Potand; 
Academic Curdiotogy Unit, St. Mary's Hospital Medical School, London, UK 
Neutmphil (PMN)-mndiated myocardial inJmy during acute myocardial in- 
famtion (AMI) Is known to be related to expression of adhesion molecules 
by PMN, These molecules mediate PMN-endothelial adherence and sub- 
sequent PMN extmvesation. PMN activation during AMI may be a result 
of PMN contact with iscllasmic endolhelium and/or release of soluble nou- 
trophilio stimuli from the infarcted area. To investigate whether peripheral 
blood may contain factors capable of modulation of PMN CD11b/CD18 Inte- 
0dn and L-selectin (CD62L) expression dudng AMI we have cofected plasma 
samples fron 12 consecutive patients with myocardial infarction immediately 
after admission, 6 h, 1, 2, 5 and 7 days later. Plasma samples were incubated 
with washed PMN from healthy donors and the expression of CD18, CD11b 
and C062L antigens was measured by flow cytometry with the use of specif'¢ 
antibodies. 
Adm. 6h 1 day 2days 5 days. 7days 
CD11b: 223±27 279-~28" 272±26* 224:E2~ 207~:32 150±31 
CD18: 18.5+2.4 20.9~-2.1 = 20.8±2.7* 17.1-1-2.0 13.3'+'1.9 7.17±2.1 
C062L: 3.38±0.41" 3,91 ±0.61" 4.11 "¢-0.42 4.41 -I-0.51 4.23::E0.65 4.81:1:1.1 
*p < 0.05 vs 5-7 day, mean ± SEM 
Conclusion: During first 48 h follo~,l~ myocardial infarction soluble stimuli 
capable of stimulation of PMN integdn expression and L-sslectin shedding 
am released into peripheral blood. This may result in systemic as well as 
intracardiao PMN activation. PMN L-selectin shedding suggests that this 
molecule acts as a homing PMN receptor. 
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~ 7  Reversal of I.lypoxic Cardlomyocyte Death by 
Selective Repair of Sercolemmal Lesions With 
Myosin-Specific Immunollpoaomes 
Jagat Naruta, Imran Vural, Viadimir P. Torohilin, Ban-An Khaw. 
Massachusetts General Hospital and Northeastern University, Boston, MA 
Loss of semolemmal integrity is 1he hall mark of cardiocyte death. Samolem- 
mat breaches permit unrestricted exchange of macromcteculas nd loss of 
Intracollular contents leading to coil attrition, We reasoned that an early inter- 
vention aimed at repair of sarcolemmal defects may prevent cardiomyocyte 
death. 
Loss of sercolemmal integrity exposes intrassflular myosin antigens to 
the extracellular milieu and can be specifically targeted by antimyosin ~nti- 
body (AM). If lipesemos (which are lipid bllayere similar to the sarcolemmal 
membrane) are endowed with andaco AM, these immunslipesemes (IL) may 
function as an initial plug with subsequent sealing of membrane lesions 
thereby providing a method for reversal of cell attrition. 
Cultured embryonic rat cardiocytes were incubated with AM-IL and plain 
liposemes (PL, without antibody) under severe hypoxio conditions, After 24 H 
of incubation, cardiocyte viability was assessed by Wpan blue exclusion and 
thymidine uptake studies, and compared to oardiocytes incubated without 
Uposomos in hypoxlc and normoxic onditions. Viability of hypoxio cardiocytos 
treated with AM-IL (pH]-thymidine uptake, 3,24:1:0,62 x 10 s cpm) was 
similar to normoxic (3.88 ± 0.18 x 10 s, p = 0.16), but greater than PL- 
treated (0.75 plusmn; 0.25 x 10 s, p = 0.003) or untreated hypoxic coils 
(0.11 4- 0.02 x 10 s, p = 0.0001). Localization of AM-IL and caro3ocyte 
salvage was confirmed by fluorescence and contOCal microscopy. Silver 
grain-impregnated AM-IL provided ultrastroctural evidantm of possible fusion 
of IL with the cell membrane. These salvaged coils grow and divide in culture 
similar to normal cardiocyte. 
The present study demonstrates the selective repair of sarcolemmal le- 
sions in cultured cardiocyles with AM-IL Feventing coil death. The sarcolem- 
sealing may provide a potential method for restoration of (:eli viability in 
repeffesed myocardial infarction. 
4:45 
~-~-~ Preconditioning Preserves Sereoplasmic Reticular 
funct ion 
Kadn Przyklank, Un Zhao 1, Robert A. Kioner, Gary 1". Elliott 1. Heart 
Institute, Good Samafftan Hospital and Univers~y of Southern California, 
Los Angeles CA; 1 RIBI Immunochem Inc., Hamilton MT. 
Despite intensive study, the mechanism responsible for the reduction of 
infarct size with iscbemic preconditioning (PC) remains unresolved. As regu- 
lation of ionic homeostasis - -  parlicutady calcium - -  is a crucial determinant 
of myocyte viability, we assessed the effect of both issbemlc PC and the 
pharmacologic "PC-mimetic" rn~ty l  lipid A (MLA) on sarcopla.s- 
mic reticolar (SR) function. Eighteen dogs underwent 1 h of LAD occlusion 
(CO) and 4 h of reffow: 6 controls received rio interver~on; 6 received 4 
5-min episodes of PC ischemia before CO; and 6 received MLA (35 ~ug/kg) 
24 h previously. Collateral blood flow (ml/min/g tissue) was measured dur- 
ing CO using radio-labeled microspheres, infarct size (% of the risk region) 
was delineated by tetrazolium staining, and SR function was assessed by 
quantilying the rate of 4SCa uptake (pmol/mg protein/min) in subepicard'ml 
semplus harvested from the previously ischemic LAD and remote circumflex 
(Cx) beds. 
Endo Row Infarct Size 45Ca Uptake: 
LAD Bed CxBed 
Control: 0.es ± 0.02 18±3% 0.69± 0.17~ 2.85~0.40 
PC: 0.05 ~:0.02 5 :l: 3%* %53±0.16" 235+0.35 
0.05:1= 0.02 10±3%" 1.16 d:0.13 *g 1.99 ± 0.23 
*p < 0.05 vs Control; ~}p < 0.05 vs Cx bed 
In controls, infarct size was 18% of the risk region and SR function in 
the viable peal-infarct region was profoundly depressed. In contrast. PC and 
MLA both reduced infarct size and presewed 4SCa uptake in the viable 
subepico~ium. Moreover, regression analysis revealed a significant inverse 
relationship between infarct size and SR function (r = 0.57; p < 0.01). 
These data demonstrate that SR fuection is in p~t preserved with lschernic 
preconditioning and the PC-mimetic MLA, and suggest hat improved calcium 
bomesstesls rosy contxibute to the reducticn of infarct size achieved with both 
interventions. 
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~5"]  Improvement of Cardiac Perlormanee After 
Selective Modulation of Incmmmd Inducible Nitric 
Oxide Synthase (INOS) Formation in Myocardial 
Infarction 
Stephen M. Wlidhi¢ Hiroshi Suzuki, Ryszard Dudek, Oamion Horslroan, 
Richard J. Bing. Hun~ngton Medical Research Institutes, Pasadena, CA; 
Dep~ of ~ Surgery, ~msT ians  Un/vemey, Munich, Germany 
We investigated the effects of two preferential inhibitore of increased iNOS 
activity on myocaro'ial b ood flow (MBF) and hemodynamico in rabbits with 
myocordml infarction (MI) 72h atter coronary osdusinn. New Zealand White 
Rabbits were rendemly assigned to one of the fo l~  groups: A) sham (n - 
6), B) infarct (n = 6), C) infarct + aminoguantdino (AG; 300 mg/kg/day so, n = 
6), D) infant + S-methylisetbiouma sulfate (SMT; 3 mg/kg/day iv, n = 6), Left 
ventdcular systolic (LVSP) and end-diestolic pressure (LVEDP), +dP/dt and 
A S C O 
INOS 62±1.  23.3<-4.1" 14,2 ±2~ t 11.5 ~: 1.8t 
LVSP 73.3:1:6,3 54.4 ± 7.3" 593 ± 5 66.1 ± 3.1 
+dP/dt 2985:1:622 2018:1:171" 2342 ± 234t 2546 ± 230 t
-dP/dt 2859:t:457 2043±238" 2292± lg8 t 2455 ±516t 
LVEDP 1.4 i 0.2 6.56 + 0.6" 3.54 :l: 1.9 1,73 ± 0.6 t 
MBF 1.18±0,04 0.96±0.02" 1.09 -~ 0,037 1,13 ±O.04t 
CVR 52:1=3 43±4*  46:1:8 t 47~3 
*p < 0.05~ A; t  p < 0.05vs a. 
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-dP/dt were monitored. MBF (mVmin/g) and coronary vascular resislance 
(CVR) was determined by fluorescent microspheres. Myocardial iNOS activ- 
ity (fmol//~g) was assayed by conversion of L-14C-arginlne to L-14C-citrulline 
and NO. Infarcted rabbits developed left ventdcular dysfunction; MBF in the 
surviving myccardium was significantly recfuced, iNOS Inhibition by SMT and 
AG significantly improved myocardial performance and increased MBF in 
infamted rabbits but not in sham animals, 
In conclusion the present study provides evidence that increased iNOS 
formation in MI contributes to myocardial dysfunction; selective modulation 
of this isozyme improves cardiac performance and increases MBF in the 
suwiving myccardium and may be beneficial in the treatment of the disease. 
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~ Medical Treatment With ACE-Inhibitors Prevents the 
Ischemia-lndoced Activation of  Protein Kinase C in 
Acute Myocardial Infarcl lon 
Ruth H. Strasser, Markus Dahlem, Martin Braun, Ulrike Oehl, 
Rather Marquetant. Univers,ty of Heidelberg, Germany 
In early myocardial ischemia ACE-inhibitorS have been shown to reduce 
compensatory cardiac hypertrophy and possibly to prevent myocardial re- 
modeling. An enzyme which may contribute to these processes might be 
protein kinase C (PKC). Early myocardial ischemia has been shown to in- 
duce an activation of PKC. The mechanisms leading to this activation are not 
known- 
To investigate, ifACE-inhibitors might modulate the ischemia-induced ac- 
tivation of PKC, isolated perfused rat hearts according to the method of Lan- 
geedorff were subjected to myocardial ischamia by stop of perfusion for 2.5 
min. In the ischemic hearts PKC activity increased in the plasma membranes 
(310 :l: 29 to 381:1:18 pmol/min/mg protein) with a concomitant reduction 
of the cytosolic PKC activity. This trenslocetion of PKC is s,+:ggestive of a 
rapid activation of PKC in myocardial ischamia, Prepedusion for 20 rain. 
with two different ACE-inhibitors, Enalapdlat and Ramipdlat (each 10 pg/ml), 
followed by a 2.5 min. episode of ischemia was able to completely prevent 
the ischamia.induced translocetion and activation of PKC. PKC activity beth 
in the particulate and in the cytosolic fraction remained completely unaltered 
after brief periods o! ischemia in the preoence of an effective ACE-inhibition. 
Similarly, pretreatment with Enalapdlat (25-50 pg/kg i.p.) for one week was 
also able to completely prevent an activation of PKC in acute myocardial 
infarction. 
These data demonstrate for the first time that ACE-inhibition pdor to my* 
ocardial ischemia can effectively prevent the ischemia-induce activation of 
PKC. Further studies have to show, if ACE-inhibitors mediate pert of their 
protective ffects via this newly characterized blockade of protein kinase C 
activation in the infarcted heart. 
Ass i s ted  C i rcu la t ion  
Tuesday, March 26, 1996, 4:00 p.m.-5:30 p.m. 
Orange County Convent ion Center, Room 222 
4:00 
~ Exercise Hemodynamica in Patients Chronically 
Supported With a Latt Ventricular Device: Results of 
the EVADE Pilot Trial 
Brian Jaskl, Kelley Branch, John Gordon, Robert Adamson, 
Peter Hoagland, I_am/Favrot, Richard Maly, Walter Dembitsky. Sharp 
Memorial HOSp#a/, San Diego, CA 92123 
As a pilot for the Experience with LVAD with Exercise (EVADE) trial, 10 
patients implanted with the Thermo Cardiosystems LVAD (8 pneumatic, 2 
vented alectdc) were assessed (ran ± SD) 46 ± 25 days pest-implant with 
supine bicycle exercise. VAD rate (VR), Fick cardiac (CO) and VAD (VO) 
output, right atrial (RA), pulmonary artery (PA), wedge (PCW), and radial 
artedal (BP) pressures (ram Hg), mixed venous 02 content (PAsat), and 02 
consumption (02) were: 
HR VR BP RA PA 
Rest 87±12 82<-18 94<-13 6±4 17±3 
Exercise 108<-17 107±21 103:J: 13 12:E5 31 :J: 7 
PCW CO (I/m) VO (I/m) PAsat (%) O2(-cc/kg/m ) 
Resi" 5<-3 5.0 ± 1.2 5,4±0.9 67+5 2.8:1:0+4 
Exercise 14±8 7.8 <- 2.5 7.0<-1.4 39±10 8.2 d: 1.7 
With exercise, CO increased more than VO (p < 0.05) and Doppler-echo 
showed LV ejection through the native aortic valve. Peak upright treadmill 
exercise 02 was 14.6 4- 2.9 (p < 0.005 ~,  supine bike). Hemoglobin (Hgb) 
was 10.5:1:1.2. Plasma flee Hgb was not elevated in any patient. 
Thus: 1) Despite postoperative anemia, circulatory reserve allowed exer- 
cise compatible with activities of dally life associated with mederate levations 
in dght and left heart filing pressures. 2) The LV and LVAD operate as ssdos 
pumps at rest, but as parallel pumps at peak exercise when increased left 
heart filling pressure permits LV ejection through the native aortic valve. 3) 
O~ consumption was higher with upright readmill compared to supine bike 
exercise. 
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I "~ '~ Effec'l o f  Percuteneous Cardlopulmonary Support 
on Coronary Artery Row Velocity 
ToyoJi Nemoto, Kazuo Kimura, Tomoakl Shlmizu, Yasuyuki Mochfda, 
Masami Kosuge, Naomitsu Kujt, Toshiyuki Ishikawa, Naomichi Miyasaki, 
Osamu To~hikubo, Masao Ishii. Yokohama City University, Yokohama, 
Japan 
Purpose of this study was to assess the effect of PCPS on coronary artery 
flow velocity (CAFV) and its waveform, using intravascular Doppler guide 
wire. PCPS were performed as circulatory support for left main trunk (LMT} 
stsnting in two patients and as rosustation measures for bystander Cardio- 
pulmonary arrest in six patients with acute myocardial infarction. The CAFV 
was recorded in normal coronary artery without stenosis (> 25%) dudng 
pump on and off, or during stepwise decrease in pump flow. In the patients 
(n = 2) with normal sinus rhythm after successful LMT stanting, the CAFV 
was normal dudng pump off, and PCPS increased it without changes in its 
waveform pettem. In the patient (n = 1) with ventdcular standstill, PCPS 
increased mean CAFV from zero to 55 cm/sec with non-pulsatile flow. In the 
patients (n = 5) undergoing circulatory-pulmonary resustation, native coro- 
nary flow under ventricular hythm during pump off indicated charactedstic 
findings, such as marked decrease in systolic antegrade flow, appearance 
of abnormal broad systolic retrograde flow (SRF) and rapid deceleration of 
diastolic antegrade flow (DAF). Circulatory assist of PCPS increased mean 
CAFV and improved the efficient coronary circulation, which was indicated 
by OAF minus SRF. In conclusion, PCPS may increase coronary artery flow 
and improve abnormal CAFV waveform impairecl by cardiac dete,-ioralion. 
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~ Temporary Mechanical Support Wilh the BVS 5000 
Assist Device During Treatment of  Acute Viral 
Myocarditi.s 
Daniel Mare,i, Hi,el Laks, Abbas Ardshali, Bram Amsel, Gregory Couper, 
G. Kimble Jett, Aivaro Galindo, Davis C. Ddnkwater. UCLA Medical Center, 
Los Angeles, California 
Ventricuiar support with the BVS 5000 (Abiomed) has been used as tempe- 
rary circulatory assist for the failing heart. Our purpose is to summarize four 
cases illustrating the role of mechanical unloading in acute myocarditis. 
Four patients aged 16-33 y.o. presented with CHF 4-20 days after a 
flu-like syndrome. All patients were in severe cerdiogenic shock :t: renal and 
liver dysfunction. EF ranged from 5-26%. Indications for ventdcular assist 
were failure of maximal medical treatment with _> two inotmpes :t: IABP. 
Myocardial biopsy revealed acute myocarditis in three patients and severe 
edema in one despite a charactsdstic linical course, Two patients received 
immunotharapy with OKT3. Biventdcular assist was used in three patients 
and left ventricular assist only was used in one. Mean support time was 
0.3 days (7-11). All patients had recovery of myocardial function and were 
discharged from the hospital in good condition. 
Conclusion: The BVS 5000 device provides a safe, simple, and effective 
method to support the circulation during acute myocarditis. We hypothesize 
that this may facilitate myocardial recovery by decompressing the distended 
ventricle. Ventdcular assist devices should be used eady in the presence of 
detsdoration on maximal medical therapy. 
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~ Computer Model Predicts Alterat ions in Stroke 
Volume After Cardiomyoplasty 
Rashid M. Ahmad, Brian J. DeGuzman, David B. Lautz, Frederick Y. Chert, 
Rite G. Laurence, Lawrence H. Cohn. Brigham & Women's Hospital, 
Goston, MA 02115 
We developed a computer model to predict alterations in SV following dy- 
namic cardiomyoplasty (DCM). The model examined the effects of LV size 
and shape, and degree of latissimus dorei muscle tiber shortening (LDMFS) 
to predict changes in SV. The model provides an explanation as to why 
significant augmentation in SV has not been seen clinicaUy after DCM. Input 
